Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma

    Despite the advent of neoadjuvant chemoradiotherapy (CRT), overall survival rates of esophageal adenocarcinoma (EAC) remain low. A readily induced mesenchymal transition of EAC cells contributes to resistance ...

    Amber P. van der Zalm, Mark P. G. Dings, Paul Manoukian in Communications Medicine (2024)

  2. Article

    Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have ...

    Ilio Vitale, Federico Pietrocola, Emma Guilbaud in Cell Death & Differentiation (2023)

  3. Article

    Open Access

    Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer

    Colorectal cancer (CRC) can be divided into four consensus molecular subtypes (CMS), each with distinct biological features. CMS4 is associated with epithelial-mesenchymal transition and stromal infiltration (...

    Joyce Y. Buikhuisen in Journal of Experimental & Clinical Cancer … (2023)

  4. Article

    Open Access

    Molecular characterization of colorectal cancer related peritoneal metastatic disease

    A significant proportion of colorectal cancer (CRC) patients develop peritoneal metastases (PM) in the course of their disease. PMs are associated with a poor quality of life, significant morbidity and dismal ...

    Kristiaan J. Lenos, Sander Bach, Leandro Ferreira Moreno in Nature Communications (2022)

  5. Article

    Open Access

    Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer

    Recently it has been recognized that stromal markers could be used as a clinically relevant biomarker for therapy response and prognosis. Here, we report on a serum marker for stromal activation, A Disintegrin...

    Sanne ten Hoorn, Cynthia Waasdorp, Martijn G. H. van Oijen, Helene Damhofer in BMC Cancer (2022)

  6. Article

    Open Access

    BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer

    Evasion of apoptosis is a hallmark of cancer, which is frequently mediated by upregulation of the antiapoptotic BCL-2 family proteins. In colorectal cancer (CRC), previous work has highlighted differential ant...

    Prashanthi Ramesh, Tamsin R. M. Lannagan, Rene Jackstadt in Cell Death & Differentiation (2021)

  7. Article

    Open Access

    Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery

    Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic prope...

    Simone Di Franco, Paola Bianca, Davide Stefano Sardina in Nature Communications (2021)

  8. Article

    Open Access

    Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis

    Right-sided (proximal) colorectal cancer (CRC) has a poor prognosis and a distinct mutational profile, characterized by oncogenic BRAF mutations and aberrations in mismatch repair and TGFβ signalling. Here, we de...

    Joshua D. G. Leach, Nikola Vlahov, Petros Tsantoulis in Nature Communications (2021)

  9. No Access

    Article

    Apc-mutant cells act as supercompetitors in intestinal tumour initiation

    A delicate equilibrium of WNT agonists and antagonists in the intestinal stem cell (ISC) niche is critical to maintaining the ISC compartment, as it accommodates the rapid renewal of the gut lining. Disruption...

    Sanne M. van Neerven, Nina E. de Groot, Lisanne E. Nijman, Brendon P. Scicluna in Nature (2021)

  10. Article

    Open Access

    Chromosomal copy number heterogeneity predicts survival rates across cancers

    Survival rates of cancer patients vary widely within and between malignancies. While genetic aberrations are at the root of all cancers, individual genomic features cannot explain these distinct disease outcom...

    Erik van Dijk, Tom van den Bosch, Kristiaan J. Lenos in Nature Communications (2021)

  11. Article

    Open Access

    Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges

    Colon cancer inter-tumour heterogeneity is installed on multiple levels, ranging from (epi)genetic driver events to signalling pathway rewiring reflected by differential gene expression patterns. Although the ...

    Joyce Y. Buikhuisen, Arezo Torang, Jan Paul Medema in Oncogenesis (2020)

  12. Article

    Open Access

    BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

    Apoptosis is a form of programmed cell death that is essential for tissue homeostasis. De-regulation of the balance between proliferation and apoptosis contributes to tumor initiation. Particularly in the colo...

    Prashanthi Ramesh, Jan Paul Medema in Apoptosis (2020)

  13. Article

    Open Access

    Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

    Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis of all common cancers. However, divergent outcomes exist between patients, suggesting distinct underlying tumor biology. Here, we delineated this...

    Frederike Dijk, Veronique L. Veenstra, Eline C. Soer in Scientific Reports (2020)

  14. No Access

    Protocol

    Isolation, Propagation, and Clonogenicity of Intestinal Stem Cells

    Intestinal stem cell research has greatly aided our understanding of the biology of intestinal self-renewal but has also shed light on the role of cancer stem cells (CSCs) in carcinogenesis, cancer growth, and...

    Prashanthi Ramesh, Aleksandar Buryanov Kirov, David Johannes Huels in Stem Cell Niche (2019)

  15. No Access

    Article

    Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer

    Solid malignancies have been speculated to depend on cancer stem cells (CSCs) for expansion and relapse after therapy. Here we report on quantitative analyses of lineage tracing data from primary colon cancer ...

    Kristiaan J. Lenos, Daniël M. Miedema, Sophie C. Lodestijn in Nature Cell Biology (2018)

  16. Article

    Open Access

    Patched-2 functions to limit Patched-1 deficient skin cancer growth

    Basal cell carcinoma (BCC) is one of the most common skin cancers, and is typically driven by an aberrantly activated Hedgehog (Hh) pathway. The Hh pathway is regulated by interactions between the Patched-1 (P...

    Veronique L. Veenstra, Ilse Dingjan, Cynthia Waasdorp, Helene Damhofer in Cellular Oncology (2018)

  17. No Access

    Article

    Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells

    Memory T cells are critical for the immune response to recurring infections. Their instantaneous reactivity to pathogens is empowered by the persistent expression of cytokine-encoding mRNAs. How the translatio...

    Fiamma Salerno, Sander Engels, Maartje van den Biggelaar in Nature Immunology (2018)

  18. Article

    Open Access

    Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives....

    Lorenzo Galluzzi, Ilio Vitale, Stuart A. Aaronson in Cell Death & Differentiation (2018)

  19. No Access

    Article

    Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models

    Colorectal cancer (CRC) is a highly heterogeneous disease both from a molecular and clinical perspective. Several distinct molecular entities, such as microsatellite instability (MSI), have been defined that m...

    Janneke F. Linnekamp, Sander R. van Hooff in Cell Death & Differentiation (2018)

  20. Article

    Open Access

    Intra-tumor heterogeneity from a cancer stem cell perspective

    Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra...

    Pramudita R. Prasetyanti, Jan Paul Medema in Molecular Cancer (2017)

previous disabled Page of 3